PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview, page-2

  1. 132 Posts.
    lightbulb Created with Sketch. 16
    thanks for sharing..
    "certainly got on the radar of a lot of commercial companies"..
    very nice
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.